recombinant subunit Herpes zoster vaccine
ApprovedVaccine
recombinant subunit Herpes zoster vaccine is one of 82 biologic programs targeting Rheumatic Disease. It is currently in Approved.
2
Indications
2
Total Trials
1
Active Trials
81
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
92 competitors in Herpes Zoster
#DrugCompanyPhaseTrials
1Fluzone
SanofiPhase 3
Herpes Zoster Vaccine 1437173a
GSKPhase 3
Rsvpref3 Vaccine
GSKPhase 3
GSK 257049
GSKPhase 3
Prevenar13
GSKPhase 3
Boostrix
GSKPhase 3
Valtrex
GGlaxo Dba Glaxosmithkline
Phase 2
recombinant subunit Herpes zoster vaccine
UUniversity Health Network, Toronto
Approved
Hz/su VACCINE
GSKPhase 3
Valaciclovir
GSKPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details